KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Clover Health Investments (CLOV) Depreciation & Amortization (IS) (2020 - 2025)

Clover Health Investments' Depreciation & Amortization (IS) history spans 6 years, with the latest figure at $420000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (IS) rose 22.09% year-over-year to $420000.0; the TTM value through Dec 2025 reached $1.7 million, up 26.67%, while the annual FY2025 figure was $1.7 million, 26.67% up from the prior year.
  • Depreciation & Amortization (IS) reached $420000.0 in Q4 2025 per CLOV's latest filing, up from $406000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $999000.0 in Q2 2023 to a low of -$841000.0 in Q4 2022.
  • Average Depreciation & Amortization (IS) over 5 years is $397950.0, with a median of $400000.0 recorded in 2025.
  • Peak YoY movement for Depreciation & Amortization (IS): surged 497.18% in 2021, then tumbled 199.17% in 2022.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $848000.0 in 2021, then tumbled by 199.17% to -$841000.0 in 2022, then surged by 180.14% to $674000.0 in 2023, then plummeted by 48.96% to $344000.0 in 2024, then grew by 22.09% to $420000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Depreciation & Amortization (IS) are $420000.0 (Q4 2025), $406000.0 (Q3 2025), and $394000.0 (Q2 2025).